Dow Down 0.39% Nasdaq Up 0.05%

Salix Pharmaceuticals Ltd. (SLXP)

-NasdaqGS
158.13 Down 0.98(0.62%) 1:21PM EDT - Nasdaq Real Time Price
Prev Close:159.11
Open:158.95
Bid:157.81 x 100
Ask:158.03 x 400
1y Target Est:158.38
Beta:1.14
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:157.87 - 160.88
52wk Range:65.14 - 162.38
Volume:372,752
Avg Vol (3m):1,301,760
Market Cap:10.07B
P/E (ttm):134.35
EPS (ttm):1.18
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SLXP

Comparison

Symbol% ChgMkt Cap
SLXPDown 0.62%10.07B
BAYRYUp 0.15%111.22B
GSKDown 1.87%115.73B
WCRX 0.00%N/A

Key Statistics

Forward P/E (1 yr):22.62
P/S (ttm):8.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :6.17
Quarterly EPS Est (Sep-14) :1.56
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.34

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs and medical devices to treat various gastrointestinal diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback